This study aims to: investigate the expression of CLDN18.2 in ICC; analyze the correlation between CLDN18.2 expression and clinicopathological characteristics and prognosis of ICC; and explore its relationship with the TIME in ICC, particularly CD8+ tumor-infiltrating lymphocytes (TILs). The gene discussed is CD8A; the disease is intrahepatic cholangiocarcinoma.